Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006 - 20/10/11
, Mona Saraiya, MD, MPH b, Pragna Patel, MD, MPH c, Sai S. Cherala, MD, MPH e, Jill Barnholtz-Sloan, PhD, MS f, Julian Kim, MD g, Charles L. Wiggins, PhD h, Phyllis A. Wingo, PhD d
Reprint requests: Ahmedin Jemal, DVM, PhD, American Cancer Society, 250 Williams St NW, Atlanta, GA 30303.Abstract |
Background |
Increasing cutaneous melanoma incidence rates in the United States have been attributed to heightened detection of thin (≤1-mm) lesions.
Objective |
We sought to describe melanoma incidence and mortality trends in the 12 cancer registries covered by the Surveillance, Epidemiology, and End Results program and to estimate the contribution of thin lesions to melanoma mortality.
Methods |
We used joinpoint analysis of Surveillance, Epidemiology, and End Results incidence and mortality data from 1992 to 2006.
Results |
During 1992 through 2006, melanoma incidence rates among non-Hispanic whites increased for all ages and tumor thicknesses. Death rates increased for older (>65 years) but not younger persons. Between 1998 to 1999 and 2004 to 2005, melanoma death rates associated with thin lesions increased and accounted for about 30% of the total melanoma deaths.
Limitations |
Availability of long-term incidence data for 14% of the US population was a limitation.
Conclusions |
The continued increases in melanoma death rates for older persons and for thin lesions suggest that the increases may partly reflect increased ultraviolet radiation exposure. The substantial contribution of thin lesions to melanoma mortality underscores the importance of standard wide excision techniques and the need for molecular characterization of the lesions for aggressive forms.
Le texte complet de cet article est disponible en PDF.Key words : incidence, melanoma, mortality, SEER (Surveillance, Epidemiology, and End Results), tumor thickness
Abbreviations used : AAD, APC, RR, SEER
Plan
| Publication of this supplement to the JAAD was supported by the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC). |
|
| Conflicts of interest: None declared. |
|
| The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions, recommendations, or official position of the journal editors or the Centers for Disease Control and Prevention. |
Vol 65 - N° 5S1
P. S17.e1-S17.e11 - novembre 2011 Retour au numéro
Article précédent
- Melanoma surveillance in the United States: Overview of methods
- Meg Watson, Christopher J. Johnson, Vivien W. Chen, Cheryll C. Thomas, Hannah K. Weir, Recinda Sherman, Myles Cockburn, Jeannette Jackson-Thompson, Mona Saraiya
- Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006
- Xiao-Cheng Wu, Melody J. Eide, Jessica King, Mona Saraiya, Youjie Huang, Charles Wiggins, Jill S. Barnholtz-Sloan, Nicolle Martin, Vilma Cokkinides, Jacqueline Miller, Pragna Patel, Donatus U. Ekwueme, Julian Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?